Genetic Technologies Signs on Fifth PPO for Coverage of BrevaGen | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies today announced an agreement with Three Rivers Provider Network, bringing the total number of covered lives with in-network access to the company's BrevaGen breast cancer test to more than 23 million.

Three Rivers is a supplemental preferred provider organization based in Chula Vista, Calif., and provides healthcare benefits to more than 10 million members at more than 1 million sites across the country.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.